Ondansetron reverses antihypersensitivity from clonidine in rats after peripheral nerve injury: Role of γ-aminobutyric acid in α2-adrenoceptor and 5-HT3 serotonin receptor analgesia

Anesthesiology

Volumn 117, Issue 2, 2012, Pages 389-398

  Hayashida, Ken Ichiro ^a   Kimura, Masafumi ^b   Yoshizumi, Masaru ^a   Hobo, Shotaro ^a   Obata, Hideaki ^b   Eisenach, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; 3 AMINO 2 METHYLPROPIONIC ACID; ACETYLCHOLINE; ALPHA 2 ADRENERGIC RECEPTOR; ATROPINE; CLONIDINE; DOLASETRON MESILATE; IDAZOXAN; MECAMYLAMINE; ONDANSETRON; SEROTONIN 3 RECEPTOR;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; IN VIVO STUDY; MALE; MICRODIALYSIS; NERVE LIGATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; SYNAPTOSOME;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANALGESIA; ANIMALS; CLONIDINE; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; MALE; ONDANSETRON; PAIN; PAIN MANAGEMENT; PERIPHERAL NERVE INJURIES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS;

EID: 84864286150     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318260d381     Document Type: Article

References (48)

1. Melzack R, Wall PD: Pain mechanisms: A new theory. Science 1965; 150:971-9.
2. Millan MJ: Descending control of pain. Prog Neurobiol 2002; 66:355-474.
3. Aston-Jones G, Shipley MT, Chouvet G, Ennis M, van Bockstaele E, Pieribone V, Shiekhattar R, Akaoka H, Drolet G, Astier B, Charléty P, Valentino RJ, Williams JT: Afferent regulation of locus coeruleus neurons: Anatomy, physiology and pharmacology. Prog Brain Res 1991; 88:47-75.
4. Pertovaara A: Noradrenergic pain modulation. Prog Neurobiol 2006; 80:53-83.
5. Hayashida K, Obata H, Nakajima K, Eisenach JC: Gabapentin acts within the locus coeruleus to alleviate neuropathic pain. Anesthesiology 2008; 109:1077-84.
6. Hayashida K, Clayton BA, Johnson JE, Eisenach JC: Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats. Pain 2008; 136:348-55.
7. Hayashida K, Eisenach JC: Spinal alpha 2-adrenoceptor-mediated analgesia in neuropathic pain reflects brain-derived nerve growth factor and changes in spinal cholinergic neuronal function. Anesthesiology 2010; 113:406-12.
8. Hayashida K, Eisenach JC: A tropomyosine receptor kinase inhibitor blocks spinal neuroplasticity essential for the antihypersensitivity effects of gabapentin and clonidine in rats with peripheral nerve injury. J Pain 2010; 12:94-100.
9. Pan HL, Chen SR, Eisenach JC: Intrathecal clonidine alleviates allodynia in neuropathic rats: Interaction with spinal muscarinic and nicotinic receptors. Anesthesiology 1999; 90:509-14.
10. Paqueron X, Conklin D, Eisenach JC: Plasticity in action of intrathecal clonidine to mechanical but not thermal nociception after peripheral nerve injury. Anesthesiology 2003; 99:199-204.
11. Baba H, Kohno T, Okamoto M, Goldstein PA, Shimoji K, Yoshimura M: Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn. J Physiol 1998; 508(Pt 1):83-93.
12. Chen SR, Pan HL: Spinal GABAB receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats. Brain Res 2003; 965:67-74.
13. Genzen JR, McGehee DS: Nicotinic modulation of GABAergic synaptic transmission in the spinal cord dorsal horn. Brain Res 2005; 1031:229-37.
14. Pan HL, Wu ZZ, Zhou HY, Chen SR, Zhang HM, Li DP: Modulation of pain transmission by G-protein-coupled receptors. Pharmacol Ther 2008; 117:141-61.
15. Rashid MH, Ueda H: Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res 2002; 953:53-62.
16. Zhang HM, Chen SR, Cai YQ, Richardson TE, Driver LC, Lopez-Berestein G, Pan HL: Signaling mechanisms mediating muscarinic enhancement of GABAergic synaptic transmission in the spinal cord. Neuroscience 2009; 158:1577-88.
17. Zhang HM, Li DP, Chen SR, Pan HL: M2, M3, and M4 receptor subtypes contribute to muscarinic potentiation of GABAergic inputs to spinal dorsal horn neurons. J Pharmacol Exp Ther 2005; 313:697-704.
18. Steinbusch HW: Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 1981; 6:557-618.
19. Green GM, Scarth J, Dickenson A: An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT(3) receptors in the anaesthetized rat. Pain 2000; 89:81-8.
20. Svensson CI, Tran TK, Fitzsimmons B, Yaksh TL, Hua XY: Descending serotonergic facilitation of spinal ERK activation and pain behavior. FEBS Lett 2006; 580:6629-34.
21. Dogrul A, Ossipov MH, Porreca F: Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res 2009; 1280:52-9.
22. Peters CM, Hayashida K, Ewan EE, Nakajima K, Obata H, Xu Q, Yaksh TL, Eisenach JC: Lack of analgesic efficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the rat. Brain Res 2010; 1352:83-93.
23. Okazaki R, Namba H, Yoshida H, Okai H, Miura T, Kawamura M: The antiallodynic effect of Neurotropin is mediated via activation of descending pain inhibitory systems in rats with spinal nerve ligation. Anesth Analg 2008; 107:1064-9.
24. Fukushima T, Ohtsubo T, Tsuda M, Yanagawa Y, Hori Y: Facilitatory actions of serotonin type 3 receptors on GABAergic inhibitory synaptic transmission in the spinal superficial dorsal horn. J Neurophysiol 2009; 102:1459-71.
25. Kawamata T, Omote K, Toriyabe M, Yamamoto H, Namiki A: The activation of 5-HT(3) receptors evokes GABA release in the spinal cord. Brain Res 2003; 978:250-5.
26. Kim SH, Chung JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50:355-63.
27. Yaksh TL, Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17:1031-6.
28. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53:55-63.
29. Randall LO, Selitto JJ: A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957; 111:409-19.
30. Brawek B, Löffler M, Weyerbrock A, Feuerstein TJ: Effects of gabapentin and pregabalin on K-evoked 3H-GABA and 3Hglutamate release from human neocortical synaptosomes. Naunyn Schmiedebergs Arch Pharmacol 2009; 379:361-9.
31. Eaton MJ, Plunkett JA, Karmally S, Martinez MA, Montanez K: Changes in GAD-and GABA-immunoreactivity in the spinal dorsal horn after peripheral nerve injury and promotion of recovery by lumbar transplant of immortalized serotonergic precursors. J Chem Neuroanat 1998; 16:57-72.
32. Gwak YS, Hulsebosch CE: GABA and central neuropathic pain following spinal cord injury. Neuropharmacology 2011; 60:799-808.
33. Liu J, Wolfe D, Hao S, Huang S, Glorioso JC, Mata M, Fink DJ: Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther 2004; 10:57-66.
34. Sonohata M, Furue H, Katafuchi T, Yasaka T, Doi A, Kumamoto E, Yoshimura M: Actions of noradrenaline on substantia gelatinosa neurones in the rat spinal cord revealed by in vivo patch recording. J Physiol 2004; 555:515-26.
35. Takeda D, Nakatsuka T, Papke R, Gu JG: Modulation of inhibitory synaptic activity by a non-alpha4beta2, non-alpha7 subtype of nicotinic receptors in the substantia gelatinosa of adult rat spinal cord. Pain 2003; 101:13-23.
36. Young T, Wittenauer S, Parker R, Vincler M: Peripheral nerve injury alters spinal nicotinic acetylcholine receptor pharmacology. Eur J Pharmacol 2008; 590:163-9.
37. Hayashida KI, Bynum T, Vincler M, Eisenach JC: Inhibitory M2 muscarinic receptors are upregulated in both axotomized and intact small diameter dorsal root ganglion cells after peripheral nerve injury. Neuroscience 2006; 140:259-68.
38. Bernardini N, Reeh PW, Sauer SK: Muscarinic M2 receptors inhibit heat-induced CGRP release from isolated rat skin. Neuroreport 2001; 12:2457-60.
39. Dussor GO, Helesic G, Hargreaves KM, Flores CM: Cholinergic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron. Pain 2004; 107:22-32.
40. Suzuki R, Rygh LJ, Dickenson AH: Bad news from the brain: Descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 2004; 25:613-7.
41. Suzuki R, Morcuende S, Webber M, Hunt SP, Dickenson AH: Super-ficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci 2002; 5:1319-26.
42. Zeitz KP, Guy N, Malmberg AB, Dirajlal S, Martin WJ, Sun L, Bonhaus DW, Stucky CL, Julius D, Basbaum AI: The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002; 22:1010-9.
43. Chen Y, Oatway MA, Weaver LC: Blockade of the 5-HT3 receptor for days causes sustained relief from mechanical allodynia following spinal cord injury. J Neurosci Res 2009; 87:418-24.
44. Oatway MA, Chen Y, Weaver LC: The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain 2004; 110:259-68.
45. Sasaki M, Ishizaki K, Obata H, Goto F: Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur J Pharmacol 2001; 424:45-52.
46. Machu TK: Therapeutics of 5-HT3 receptor antagonists: Current uses and future directions. Pharmacol Ther 2011; 130:338-47.
47. Simpson KH, Murphy P, Colthup PV, Whelan P: Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers. Psychopharmacology (Berl) 1992; 109:497-8.
48. Hayashida K, DeGoes S, Curry R, Eisenach JC: Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery Anesthesiology 2007; 106:557-62